Enhanced adenovirus infection of melanoma cells by fiber-modification - Incorporation of RGD peptide or Ad5/3 chimerism

被引:58
作者
Volk, AL
Rivera, AA
Kanerva, A
Bauerschmitz, G
Dmitriev, I
Nettelbeck, DM
Curiel, DT
机构
[1] Univ Alabama, Div Human Gene Therapy, Birmingham, AL USA
[2] Univ Alabama, Gene Therapy Ctr, Birmingham, AL USA
[3] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
关键词
gene therapy; adenovirus vectors; melanoma; infectivity enhancement; fiber chimerism; RGD peptide;
D O I
10.4161/cbt.2.5.440
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The incidence of malignant melanoma has been increasing. Unfortunately, advanced melanomas are rarely curable with standard therapy; therefore, new forms of treatment such as gene therapy are needed. The success of gene delivery or oncolysis depends on the nature of the vector. Adenoviral vectors are advantageous for several reasons; however, they are dependent on CAR (coxsackie and adenovirus receptor) which is deficient or heterogeneously expressed on melanoma cells in situ. Correspondingly, transduction of freshly purified melanoma cells has been shown to be minimal or variable. In order to overcome this shortcoming, it is necessary to construct tropism modified adenoviral vectors. With this goal in mind, we generated two tropism modified vectors, Ad5lucRGD which has an RGD motif incorporated into the HI loop of the fiber knob and Ad5/3luc1 which contains the tail and shaft domain of the Ad5 fiber and the knob domain of the Ad3 fiber. Herein we demonstrate that Ad5/3luc1 infects CAR-negative primary melanoma cells 1128 times better than Ad5luc1 and 34 times better than Ad5lucRGD. Furthermore we show that Ad5/3luc1 and Ad5lucRGD infect via a CAR independent route by blocking the CAR receptor. In addition, we show that the infectivity of the cells correlates with the expression of CAR and Ad3 receptors determined by FACS analysis. Therefore, Ad5/3 is very attractive as a potential therapeutic vector for malignant melanoma.
引用
收藏
页码:511 / 515
页数:5
相关论文
共 20 条
[1]  
Bauerschmitz GJ, 2002, CANCER RES, V62, P1266
[2]   Classical chemotherapy for metastatic melanoma [J].
Becker, JC ;
Kämpgen, E ;
Bröcker, EB .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (06) :503-508
[3]   Gene therapy for the treatment of cancer [J].
Buchsbaum, DJ ;
Curiel, DT .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2001, 16 (04) :275-288
[4]   Strategies to adapt adenoviral vectors for targeted delivery [J].
Curiel, DT .
ANTICANCER MOLECULES: STRUCTURE, FUNCTION, AND DESIGN, 1999, 886 :158-171
[5]   An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism [J].
Dmitriev, I ;
Krasnykh, V ;
Miller, CR ;
Wang, MH ;
Kashentseva, E ;
Mikheeva, G ;
Belousova, N ;
Curiel, DT .
JOURNAL OF VIROLOGY, 1998, 72 (12) :9706-9713
[6]   A system for the propagation of adenoviral vectors with genetically modified receptor specificities [J].
Douglas, JT ;
Miller, CR ;
Kim, M ;
Dmitriev, I ;
Mikheeva, G ;
Krasnykh, V ;
Curiel, DT .
NATURE BIOTECHNOLOGY, 1999, 17 (05) :470-475
[7]   Gene therapy for cancer (Reprinted from Eur J Cancer, vol 35, pg 867-885, 1999) [J].
Gómez-Navarro, J ;
Curiel, DT ;
Douglas, JT .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (14) :2039-2057
[8]   Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease [J].
Havenga, MJE ;
Lemckert, AAC ;
Ophorst, OJAE ;
van Meijer, M ;
Germeraad, WTV ;
Grimbergen, J ;
van den Doel, MA ;
Vogels, R ;
van Deutekom, J ;
Janson, AAM ;
de Bruijn, JD ;
Uytdehaag, F ;
Quax, PHA ;
Logtenberg, T ;
Mehtali, M ;
Bout, A .
JOURNAL OF VIROLOGY, 2002, 76 (09) :4612-4620
[9]  
Haviv YS, 2002, CANCER RES, V62, P4273
[10]   The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures [J].
Hemmi, S ;
Geertsen, R ;
Mezzacasa, A ;
Peter, I ;
Dummer, R .
HUMAN GENE THERAPY, 1998, 9 (16) :2363-2373